[Hematopoietic stem cell transplantation for malignant lymphoma]

Autologous peripheral blood stem cell transplantation (auto-PBSCT) is increasingly performed as a curative therapy for patients with malignant lymphoma. Aggressive lymphomas which have relapsed with chemo-sensitive state, and newly diagnosed cases with high risk prognostic factors are good candidates for auto-PBSCT. Clinical results and indications for hematopoietic stem cell transplantation, including other types of lymphoma, are reviewed in this paper.